Disease Activity Criteria Impact Dosing Interval Assignment in Neovascular Age-related Macular Degeneration Trials

Marco A. Zarbin, Christina Y. Weng, Nikolas J.S. London, Adrian Hock Chuan Koh, Roberto Gallego-Pinazo, Varun Chaudhary, Audrey Souverain, Ivaylo Stoilov, Philippe Margaron

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)404-407
Number of pages4
JournalOphthalmology Retina
Volume9
Issue number4
DOIs
StatePublished - Apr 2025
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Keywords

  • Criteria
  • Disease Activity
  • Durability
  • Faricimab
  • Neovascular age-related macular degeneration

Cite this